IVD Contract Manufacturing Services Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034
Page: 215 | Report Code: LS25041001 | Research Suite: Report (PDF) & Market Data (Excel)
IVD contract manufacturing services refer to the
outsourcing the production processes required for the development and
manufacturing of IVD products. These services are crucial for companies that
necessitate specialized expertise, advanced technology, and regulatory
compliance to efficiently and economically produce high-quality diagnostic
tests.
MARKET OVERVIEW
The IVD Contract Manufacturing Services market is valued at approximately USD 14.18 billion in 2023 and is projected to reach USD 32.40 billion by 2034 exhibiting a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024-2034. The importance of IVD contract manufacturing services is diversified; they offer crucial assistance that improves operational effectiveness and enables businesses to successfully negotiate challenging regulatory landscapes. These services help organizations to maintain a competitive edge and achieve greater flexibility in production capabilities in the rapidly evolving diagnostics market.
GROWTH DRIVERS
The growing prevalence of infectious diseases is one of
the main factors propelling the expansion of IVD contract manufacturing
services market. As global health challenges become more complex, the need for
diagnostic tests is increasing to rapidly and accurately identify pathogens.
This trend is increasing demand for reagents and consumables used in diagnostic
testing, driving manufacturers to outsource production to specialized contract
manufacturers who are capable of satisfying regulatory norms and quality
criteria efficiently.
Technological advancements play a crucial role in
propelling the growth of the IVD contract manufacturing services industry. The
precision and effectiveness of diagnostic tools are increasing due to
advancements such as automation, lab-on-a-chip technologies, and microfluidics.
These technologies require specialized manufacturing capabilities that many IVD
companies often do not possess in-house, prompting them to seek collaborations
with experienced contract manufacturers who are capable of manufacturing high-quality
products while adhering to stringent regulatory requirements.
MARKET
SEGMENTATION:
By Product Type
-
·
Consumables
·
Equipment
By Category -
·
Reagents
·
Systems
By Services
Types -
·
Kit Assembly Services
o
Kitting Finished Product
o
Pouch Sealing
o
Custom Packaging
o
Regulated Kit Labeling
·
Finished Device Assembly
o
Hand Assembly
o
Sourcing of Components
o
Lot Product Management
o
Quality Control
·
Shipping Services
o
Pallet Shipments
o
Warehousing
o
Temperature Monitoring
By Technology -
·
Immunoassays
·
Clinical Chemistry
·
Molecular Diagnostics
·
Hematology
·
Microbiology
·
Coagulation & Hemostasis
·
Other Technologies (Urinalysis, etc.)
By End User -
·
Medical Device Companies
·
Academic & Research Institutions
·
Other End Users (Diagnostic Laboratories, etc.)
By Region -
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
IVD Contract
Manufacturing Services Market By Product Type Segment Review:
Consumables refer to the products that are used in diagnostic testing and are typically single-use items. These consist of test strips, kits, reagents, and other supplies required to perform different diagnostic tests. The growth of the consumables segment is driven by increasing disease prevalence, advancements in technology, cost-effective outsourcing strategies, regulatory compliance needs, and rising healthcare expenditures.
IVD Contract
Manufacturing Services Market By Category Segment Review:
Reagents are crucial parts of diagnostic assays that
measure or identify particular chemicals in biological samples. The growth of
the reagents segment is driven by increasing incidence of infectious diseases,
Innovations in reagent formulations, Regulatory Compliance, and shift towards
decentralized testing environments.
IVD Contract
Manufacturing Services Market By Service Type Segment Review:
Kit assembly services entail the complete procedure of
assembling components into diagnostic test kits. The demand for kit assembly
services is driven by the growing demand for reliable and rapid testing
solutions.
IVD Contract
Manufacturing Services Market By Technology Segment Review:
In 2024, immunoassays' segment is anticipated to hold
the largest share of the market due to its applications in various fields such
as infectious diseases, oncology, and autoimmune disorders.
IVD Contract
Manufacturing Services Market By End User Segment Review:
Medical device companies are among the primary
consumers of IVD contract manufacturing services. These companies frequently
require specific knowledge and resources to effectively manufacture
high-quality diagnostic products.
IVD Contract
Manufacturing Services Market By Region Segment Review:
The market exhibits significant regional variations,
with North America leading the market in 2024 due to the established healthcare
infrastructure, and high prevalence of chronic diseases.
Regional
Synopsis:
North America is anticipated to dominate the IVD
Contract Manufacturing Services globally due to its well-developed healthcare
system that supports advanced diagnostic testing, and increasing incidence of
chronic diseases such as diabetes and cancer that necessitates more frequent
diagnostic testing.
The Europe is another crucial market, expanding
primarily due to its robust pharmaceutical industry, growing demand for
diagnostic tests, and the increasing focus on personalized medicine and early
disease detection.
The market in Asia Pacific is growing rapidly due to their
expanding healthcare markets, the rapid economic growth in its countries,
rising burden of infectious diseases, and increasing investments in medical
technology.
In Latin America, the market is poised for steady
growth due to increasing demand for diagnostic, technological advancements, and
improvements in healthcare infrastructure.
The market in the Middle East and Africa region is growing due to the rising healthcare demands and technological innovations.
Key Challenges:
One of the biggest obstacles to IVD contract
manufacturing is regulatory compliance. The industry is governed by strict
regulations from agencies such as the FDA (U.S. Food and Drug Administration)
and CE marking requirements in Europe. The process of maintaining compliance
with these evolving standards often become difficult and time-consuming,
necessitating ongoing documentation and process updates.
Maintaining high quality control (QC) standards is
crucial for ensuring the accuracy and reliability of diagnostic products.
Contract manufacturers are required to implement strong quality control systems
that include stringent testing, component traceability, and compliance with
quality management procedures throughout the manufacturing cycle. Any quality
failures are likely to lead to serious consequences, including product recalls
or regulatory penalties.
Competitive
Landscape:
The global market for IVD Contract Manufacturing
Services is characterized by a diverse range of established players, each
striving to enhance their market presence through various strategies such as partnerships
for innovation, investment in technology, offering customized solutions,
geographic expansion into emerging markets, regulatory compliance expertise,
cost-effective solutions, and sustainability initiatives.
The IVD contract manufacturing industry places a
significant emphasis on providing customized solutions that meet specific
client needs. Companies that have the ability to provide flexible manufacturing
options, such as different batch sizes or specialized packaging, are more
likely to attract diverse clientele. This flexibility enables producers to
react quickly to shifting consumer preferences and market demands.
Key Players:
·
Avioq, Inc.
·
Thermo Fisher Scientific, Inc.
·
Savyon Diagnostics
·
KMC Systems
·
Nova Biomedical
·
LRE Medical
·
Cone Bioproducts
·
Invetech, Inc.
·
TCS Biosciences Ltd.
·
Affinity Life Sciences, Inc.
·
Coris BioConcept
·
Meridian Bioscience, Inc.
·
Merck KGaA
· Other Key & Niche Players